Thrombopoietin-Receptor Agonists for Primary Immune Thrombocytopenia.
N Engl J Med. 2011 Aug 25;365(8):734-741
Authors: Imbach P, Crowther M
A young woman with immune thrombocytopenia (ITP) who has been treated with a thrombopoietin-receptor agonist presents for advice regarding long-term treatment. The agents in this therapeutic class, romiplostim and eltrombopag, are effective in increasing platelet counts.
PMID: 21864167 [PubMed - as supplied by publisher]